Welcome to our dedicated page for Us Bancorp SEC filings (Ticker: USB), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The U.S. Bancorp (USB) SEC filings page on Stock Titan brings together the company’s regulatory disclosures from the U.S. Securities and Exchange Commission, with AI-powered tools to help interpret them. As a large financial services holding company and parent of U.S. Bank National Association, U.S. Bancorp files a range of documents that shed light on its capital structure, risk profile, earnings, regulatory environment and strategic actions.
Key filings for U.S. Bancorp include annual reports on Form 10-K and quarterly reports on Form 10-Q, which provide detail on its diversified mix of consumer banking, business banking, commercial banking, institutional banking, payments and wealth management activities. These reports also discuss credit quality, funding, capital ratios and other factors relevant to a major banking organization. Stock Titan’s AI summaries can help readers navigate lengthy disclosures by highlighting segment information, risk factors and notable changes from prior periods.
Current reports on Form 8-K are especially important for tracking material events. Recent 8-K filings describe, for example, U.S. Bancorp’s agreement and plan of merger to acquire the parent of BTIG, including the structure of cash and stock consideration and the use of an exemption from registration for the shares to be issued. Other 8-Ks discuss topics such as quarterly financial results, stress capital buffer notifications from the Federal Reserve and planned capital actions, including changes to the common stock dividend.
U.S. Bancorp also has multiple classes of securities registered under Section 12(b) of the Exchange Act, including its common stock, several series of non-cumulative perpetual preferred stock represented by depositary shares, and senior notes. Filings related to these instruments, along with Forms 3, 4 and 5 for insider transactions, provide additional insight into ownership and capital structure. On Stock Titan, real-time updates from EDGAR and AI-generated explanations make it easier to locate specific documents, understand Form 4 insider trading reports, and interpret complex sections of 10-K and 10-Q filings without reading every page.
U.S. Bancorp is issuing $12,668,000 of senior medium-term notes that pay fixed interest and can be called early. The notes carry a 5.05% annual interest rate, paid each February 11 from February 11, 2027 until maturity on February 11, 2037, unless redeemed earlier.
U.S. Bancorp may redeem the notes at par plus accrued interest on February 11, May 11, August 11 and November 11 of each year from February 11, 2028 through November 11, 2036. The notes are senior unsecured obligations, sold at 100% of principal, with proceeds to the issuer of about $12.54 million after selling commissions.
U.S. Bancorp is issuing $7,019,000 of senior medium-term notes with a fixed 5.20% annual interest rate.
The notes mature on January 28, 2041, pay interest each February 11 starting in 2027, and are callable at U.S. Bancorp’s option at par plus accrued interest on February 11, May 11, August 11 and November 11 from August 11, 2028 through November 11, 2040.
The notes are issued in $1,000 denominations at 100% of principal, with total underwriting fees and commissions of $137,551.34 and net proceeds of $6,881,448.66 before expenses. They are senior unsecured obligations, not FDIC insured, and the company highlights credit risk, limited liquidity, potential early redemption, and sensitivity of secondary prices to interest rates, credit spreads and embedded dealer and hedging costs.
U.S. Bancorp is offering $3,000,000 of senior unsecured medium-term notes with a fixed interest rate of 4.70% per year, maturing on January 28, 2036. The notes can be redeemed at U.S. Bancorp’s option at par plus accrued interest on February 11, May 11, August 11 and November 11 from 2031 through 2035.
Interest is paid annually in arrears on February 11 of each year, starting February 11, 2027, using a 30/360 day count. The minimum denomination is $1,000. The price to the public is $1,000 per note, with up to $14.01 per note in selling commissions, resulting in approximately $2,957,970 of proceeds to U.S. Bancorp before expenses.
The notes rank as senior unsecured obligations, are not bank deposits, and are not insured by the FDIC or any government agency. They are expected to be delivered in book-entry form through DTC and will not be listed on any securities exchange. The filing highlights risks including call risk, limited or no secondary market, price sensitivity to interest rates and credit spreads, potential conflicts of interest with U.S. Bancorp Investments, Inc., and exposure to U.S. Bancorp’s creditworthiness.
U.S. Bancorp is issuing $3,438,000 of senior medium-term callable fixed-rate notes due February 11, 2046. The notes pay a fixed interest rate of 5.50% per annum, with interest paid monthly on the 11th day from March 11, 2026 until maturity, unless redeemed earlier.
The notes are redeemable at U.S. Bancorp’s option, in whole but not in part, on monthly Redemption Dates starting February 11, 2027 at 100% of principal plus accrued interest. They are senior unsecured obligations, not FDIC insured, and are subject to U.S. Bancorp’s credit risk and limited expected secondary market liquidity.
US Bancorp Vice Chair Mark G. Runkel reported stock transactions on February 6, 2026. He exercised an employee stock option for 15,339 shares of common stock at an exercise price of $55.01 per share, converting the option into shares.
On the same day, he sold 32,195 shares of common stock at a weighted average price of $60.648 per share, with actual sale prices ranging from $60.630 to $60.661. After these transactions, he directly owned 97,728 shares, and indirectly held 458 shares through a 401(k) plan and 2,846 shares through a trust. The exercised options had vested in four equal installments beginning on February 16, 2018.
A security holder of the issuer has filed a Rule 144 notice to sell 32,195 shares of common stock through Fidelity Brokerage Services LLC on the NYSE, with an aggregate market value of $1,952,577.99 and an approximate sale date of 02/06/2026.
The filing notes that 1,554,434,067 shares of this class were outstanding and details that the shares to be sold were acquired mainly through option grants and restricted stock vesting between 2017 and 2024, paid for via cash and equity compensation.
U.S. Bancorp is offering senior medium-term callable fixed-rate notes due February 20, 2041 as part of its Series CC program. The notes pay a fixed interest rate of 5.40% per annum, with interest paid annually on February 20, beginning in 2027.
The notes are issued in $1,000 minimum denominations at 100% of principal amount, in U.S. dollars. U.S. Bancorp may, at its option, redeem the notes in whole (but not in part) at par plus accrued interest on February 20, May 20, August 20, and November 20 of each year, from August 20, 2028 through November 20, 2040.
The notes are senior, unsecured obligations of U.S. Bancorp and are not insured by the FDIC or any government agency. Key risks highlighted include the issuer’s credit risk, the possibility of early redemption reducing future interest payments, potential price declines if sold before maturity, limited or no secondary market, and conflicts of interest because an affiliate, U.S. Bancorp Investments, Inc., acts as distributor and may make markets in the notes.
U.S. Bancorp is offering senior unsecured medium-term notes with a fixed interest rate of 5.20% per annum, maturing on or about February 20, 2041. The notes are designed for investors seeking fixed income but accepting the risk of early redemption.
The notes pay annual interest in arrears each February 20, starting in 2027, based on a 30/360 day count, in $1,000 minimum denominations at 100% of principal. U.S. Bancorp may redeem them, in whole but not in part, on specified quarterly redemption dates from August 20, 2028 through November 20, 2040 at par plus accrued interest.
The notes will not be listed on any securities exchange, are not FDIC insured, and all payments depend on U.S. Bancorp’s credit. U.S. Bancorp Investments, Inc., an affiliate and FINRA member, will distribute the notes, with selling commissions up to $40 per $1,000 principal amount and potential resale prices between $960 and $1,000 for certain accounts.
U.S. Bancorp is offering senior unsecured Medium-Term Notes with a fixed interest rate of 5.30% per annum, expected to mature on February 20, 2044. Interest is paid in arrears each year on February 20, beginning February 20, 2027, using a 30/360 day-count convention.
The notes are callable at the issuer’s option at 100% of principal plus accrued interest on February 20, May 20, August 20 and November 20 of each year, from February 20, 2029 through November 20, 2043. They are issued in $1,000 minimum denominations, are not listed on any exchange, and are not FDIC insured. Key risks include call risk, price sensitivity to interest rates and U.S. Bancorp’s credit, potential conflicts of interest involving U.S. Bancorp Investments, Inc., and possible adverse tax law changes.
U.S. Bancorp is offering senior unsecured medium‑term notes that pay fixed interest of 5.30% per annum and are scheduled to mature on February 20, 2046. Interest is paid monthly in arrears on the 20th of each month, using a 30/360 day count convention.
The notes are callable at U.S. Bancorp’s option at par plus accrued interest on February 20, May 20, August 20 and November 20 of each year, starting February 20, 2029 and ending November 20, 2045. They are issued in $1,000 minimum denominations and are not listed on any securities exchange.
USBI, an affiliated broker‑dealer, will distribute the notes and may receive selling commissions of up to $40 per $1,000 principal amount. The pricing supplement highlights risks including early redemption and reinvestment risk, potential illiquidity and price discounts in any secondary market, and full exposure to U.S. Bancorp’s credit risk.